1. Home
  2. AISP vs WHWK Comparison

AISP vs WHWK Comparison

Compare AISP & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Airship AI Holdings Inc.

AISP

Airship AI Holdings Inc.

HOLD

Current Price

$3.00

Market Cap

112.1M

Sector

Finance

ML Signal

HOLD

WHWK

Whitehawk Therapeutics Inc.

HOLD

Current Price

$2.61

Market Cap

95.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AISP
WHWK
Founded
2006
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.1M
95.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AISP
WHWK
Price
$3.00
$2.61
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
770.3K
168.6K
Earning Date
11-17-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$12,033,886.00
$14,384,000.00
Revenue This Year
$34.52
N/A
Revenue Next Year
$59.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.79
$1.39
52 Week High
$7.66
$3.81

Technical Indicators

Market Signals
Indicator
AISP
WHWK
Relative Strength Index (RSI) 38.09 57.36
Support Level $2.79 $2.30
Resistance Level $3.13 $2.63
Average True Range (ATR) 0.22 0.16
MACD -0.02 0.00
Stochastic Oscillator 19.45 74.47

Price Performance

Historical Comparison
AISP
WHWK

About AISP Airship AI Holdings Inc.

Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where need it, using a secure permission-based architecture.

About WHWK Whitehawk Therapeutics Inc.

Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.

Share on Social Networks: